Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4H4I8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 155 | 159 | PF00656 | 0.341 |
CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.314 |
CLV_NRD_NRD_1 | 118 | 120 | PF00675 | 0.361 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.463 |
CLV_PCSK_KEX2_1 | 109 | 111 | PF00082 | 0.323 |
CLV_PCSK_SKI1_1 | 17 | 21 | PF00082 | 0.404 |
CLV_PCSK_SKI1_1 | 271 | 275 | PF00082 | 0.611 |
CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.359 |
DEG_APCC_DBOX_1 | 55 | 63 | PF00400 | 0.378 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.625 |
DEG_SPOP_SBC_1 | 7 | 11 | PF00917 | 0.532 |
DOC_CKS1_1 | 92 | 97 | PF01111 | 0.252 |
DOC_CYCLIN_yCln2_LP_2 | 46 | 52 | PF00134 | 0.467 |
DOC_MAPK_gen_1 | 109 | 118 | PF00069 | 0.304 |
DOC_MAPK_MEF2A_6 | 109 | 118 | PF00069 | 0.320 |
DOC_MAPK_MEF2A_6 | 180 | 188 | PF00069 | 0.362 |
DOC_MAPK_RevD_3 | 96 | 111 | PF00069 | 0.469 |
DOC_USP7_MATH_1 | 7 | 11 | PF00917 | 0.663 |
DOC_WW_Pin1_4 | 166 | 171 | PF00397 | 0.459 |
DOC_WW_Pin1_4 | 45 | 50 | PF00397 | 0.513 |
DOC_WW_Pin1_4 | 91 | 96 | PF00397 | 0.266 |
LIG_14-3-3_CanoR_1 | 45 | 49 | PF00244 | 0.394 |
LIG_AP2alpha_1 | 160 | 164 | PF02296 | 0.410 |
LIG_deltaCOP1_diTrp_1 | 197 | 204 | PF00928 | 0.456 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.317 |
LIG_FHA_1 | 124 | 130 | PF00498 | 0.443 |
LIG_FHA_1 | 268 | 274 | PF00498 | 0.587 |
LIG_FHA_1 | 92 | 98 | PF00498 | 0.470 |
LIG_FHA_2 | 173 | 179 | PF00498 | 0.324 |
LIG_FHA_2 | 192 | 198 | PF00498 | 0.363 |
LIG_FHA_2 | 243 | 249 | PF00498 | 0.534 |
LIG_FHA_2 | 252 | 258 | PF00498 | 0.532 |
LIG_LIR_Apic_2 | 255 | 261 | PF02991 | 0.608 |
LIG_LIR_Gen_1 | 128 | 138 | PF02991 | 0.379 |
LIG_LIR_Gen_1 | 158 | 166 | PF02991 | 0.328 |
LIG_LIR_Gen_1 | 68 | 79 | PF02991 | 0.302 |
LIG_LIR_Nem_3 | 128 | 134 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 135 | 141 | PF02991 | 0.388 |
LIG_LIR_Nem_3 | 158 | 164 | PF02991 | 0.330 |
LIG_Pex14_2 | 160 | 164 | PF04695 | 0.337 |
LIG_SH2_CRK | 131 | 135 | PF00017 | 0.497 |
LIG_SH2_CRK | 138 | 142 | PF00017 | 0.514 |
LIG_SH2_CRK | 258 | 262 | PF00017 | 0.605 |
LIG_SH2_CRK | 263 | 267 | PF00017 | 0.587 |
LIG_SH2_STAP1 | 112 | 116 | PF00017 | 0.283 |
LIG_SH2_STAT3 | 226 | 229 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 182 | 185 | PF00017 | 0.299 |
LIG_SH2_STAT5 | 242 | 245 | PF00017 | 0.638 |
LIG_SH3_2 | 105 | 110 | PF14604 | 0.442 |
LIG_SH3_3 | 102 | 108 | PF00018 | 0.446 |
LIG_SUMO_SIM_par_1 | 3 | 11 | PF11976 | 0.400 |
LIG_TYR_ITIM | 129 | 134 | PF00017 | 0.484 |
MOD_CK1_1 | 100 | 106 | PF00069 | 0.528 |
MOD_CK1_1 | 130 | 136 | PF00069 | 0.473 |
MOD_CK1_1 | 218 | 224 | PF00069 | 0.535 |
MOD_CK1_1 | 227 | 233 | PF00069 | 0.470 |
MOD_CK1_1 | 48 | 54 | PF00069 | 0.450 |
MOD_CK2_1 | 130 | 136 | PF00069 | 0.293 |
MOD_CK2_1 | 166 | 172 | PF00069 | 0.469 |
MOD_CK2_1 | 191 | 197 | PF00069 | 0.460 |
MOD_CK2_1 | 242 | 248 | PF00069 | 0.568 |
MOD_CK2_1 | 7 | 13 | PF00069 | 0.526 |
MOD_GlcNHglycan | 122 | 126 | PF01048 | 0.294 |
MOD_GlcNHglycan | 254 | 257 | PF01048 | 0.643 |
MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.408 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.412 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.502 |
MOD_GSK3_1 | 252 | 259 | PF00069 | 0.606 |
MOD_GSK3_1 | 274 | 281 | PF00069 | 0.576 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.401 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.431 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.620 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.622 |
MOD_NEK2_1 | 12 | 17 | PF00069 | 0.580 |
MOD_NEK2_1 | 198 | 203 | PF00069 | 0.388 |
MOD_NEK2_1 | 241 | 246 | PF00069 | 0.558 |
MOD_NEK2_1 | 97 | 102 | PF00069 | 0.322 |
MOD_PK_1 | 60 | 66 | PF00069 | 0.449 |
MOD_PKA_2 | 227 | 233 | PF00069 | 0.600 |
MOD_PKA_2 | 44 | 50 | PF00069 | 0.323 |
MOD_Plk_1 | 256 | 262 | PF00069 | 0.499 |
MOD_Plk_1 | 60 | 66 | PF00069 | 0.400 |
MOD_Plk_2-3 | 172 | 178 | PF00069 | 0.250 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.400 |
MOD_Plk_4 | 15 | 21 | PF00069 | 0.294 |
MOD_Plk_4 | 184 | 190 | PF00069 | 0.220 |
MOD_ProDKin_1 | 166 | 172 | PF00069 | 0.463 |
MOD_ProDKin_1 | 45 | 51 | PF00069 | 0.509 |
MOD_ProDKin_1 | 91 | 97 | PF00069 | 0.259 |
MOD_SUMO_for_1 | 209 | 212 | PF00179 | 0.352 |
TRG_DiLeu_BaLyEn_6 | 102 | 107 | PF01217 | 0.365 |
TRG_DiLeu_BaLyEn_6 | 228 | 233 | PF01217 | 0.643 |
TRG_ENDOCYTIC_2 | 131 | 134 | PF00928 | 0.412 |
TRG_ENDOCYTIC_2 | 138 | 141 | PF00928 | 0.367 |
TRG_ENDOCYTIC_2 | 71 | 74 | PF00928 | 0.427 |
TRG_ER_diArg_1 | 108 | 110 | PF00400 | 0.299 |
TRG_Pf-PMV_PEXEL_1 | 231 | 235 | PF00026 | 0.642 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBY2 | Leptomonas seymouri | 56% | 97% |
A0A0S4KGV5 | Bodo saltans | 29% | 100% |
A0A1X0NK20 | Trypanosomatidae | 32% | 90% |
A0A3R7M8M9 | Trypanosoma rangeli | 39% | 100% |
A0A3S7WPB5 | Leishmania donovani | 79% | 100% |
A4HSR3 | Leishmania infantum | 79% | 100% |
C9ZTB1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 100% |
E9AKQ0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 74% | 100% |
Q13938 | Homo sapiens | 29% | 100% |
Q4QJ57 | Leishmania major | 75% | 100% |
V5B5T8 | Trypanosoma cruzi | 38% | 100% |